This is a routine tax-withholding sale tied to RSU vesting under a pre-existing 10b5-1 plan. No discretionary insider signal. Monitor for any subsequent discretionary Form 4 filings by officers, but this filing alone carries no actionable trading signal.
IVVD drugs
IVVD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 18 $0.8680entry
- T+1 · 3mo ago +10.54%α +10.33% · $0.9595
- T+5 · 3mo ago +8.15%α +8.35% · $0.9387
- T+20 · 2mo ago −5.55%α −4.56% · $0.8198
- T+60 · 6d ago −33.82%α −31.78% · $0.5744
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Invivyd director William E. Duke filed a Form 144 to sell 40,800 shares (estimated value ~$29,413) in a non-discretionary sell-to-cover transaction to satisfy tax obligations upon RSU vesting. The sale is pre-arranged under a Rule 10b5-1 plan and represents a routine equity compensation event, not a discretionary insider sale.
Key Facts
- Reporting person: William E. Duke, an Officer of Invivyd
- Proposed sale of 40,800 shares of common stock
- Estimated aggregate market value: ~$29,413 (based on $0.7209 closing price on Aug 14, 2026)
- Sale is a non-discretionary 'sell-to-cover' transaction to satisfy tax obligations upon vesting of RSUs
- Transaction is pre-arranged under a Rule 10b5-1 plan dated Feb 20, 2025
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
~$29,413 (40,800 shares at $0.7209/share)
Risk Factors
- None from this filing, routine equity compensation event
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-354033 |
| Document: 0001193125-26-354033-index.html | 0001193125-26-354033 |
| Document: 0001193125-26-354033.txt | 0001193125-26-354033 |
Track record
19 reports on IVVD
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +35.85% at T+20 after the Jul 6, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 6/10 Entry $0.5603 Now $0.5380 −3.98% settles Nov 23
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $0.5815 to $0.5744 Now $0.5380 −7.48% ▼ −1.22% −0.63% vs SPY
- Sep 29, 20266w ago 8-K Bullish 7/10 Entry $0.8501 to $0.8064 Now $0.5380 −36.71% ▼ −5.14% −7.09% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $0.9640 to $0.8501 Now $0.5380 −44.19% ▼ −11.82% −10.63% vs SPY
- Sep 1, 202610w ago 8-K Neutral 6/10 Entry $0.8800 to $0.7973 Now $0.5380 −38.86% ▼ −9.40% −9.48% vs SPY
- Aug 17, 202613w ago 144 Neutral 2/10 Viewing Entry $0.8680 to $0.9387 Now $0.5380 −38.02% ▲ +8.15% +8.35% vs SPY
- Jul 6, 202619w ago 8-K Bearish 6/10 Entry $0.8340 to $0.7834 Now $0.5380 +35.49% ▲ +6.07% +6.56% vs SPY
- Jun 16, 202621w ago Press Release Neutral 5/10 Entry $0.8918 to $0.9346 Now $0.5380 −39.67% ▲ +4.80% +7.03% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $0.8125 to $0.9312 Now $0.5380 −33.78% ▲ +14.61% +14.18% vs SPY
- Jun 9, 202622w ago Press Release Neutral 4/10 Entry $0.9900 to $0.8686 Now $0.5380 −45.66% ▼ −12.26% −14.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers